BETA‑TT8
Cancer, cardiovascular disease, neuroinflammatory eye conditions
PreclinicalActive
Key Facts
Indication
Cancer, cardiovascular disease, neuroinflammatory eye conditions
Phase
Preclinical
Status
Active
Company
About Filamon
Australian‑focused biotech creating multi‑modal anti‑inflammatory drugs for age‑related chronic diseases.
View full company profile